Top

Advances in Therapy

Content (7 Articles)

Review

Linagliptin/Metformin Fixed-Dose Combination Treatment: A Dual Attack to Type 2 Diabetes Pathophysiology

Chrysi Koliaki, John Doupis

Review

Initial Combination with Linagliptin and Metformin in Newly Diagnosed Type 2 Diabetes and Severe Hyperglycemia

Thomas Haak

Open Access Original Research

A Cross-sectional Survey of Hypertension Diagnosis and Treatment Practices Among Physicians in Yaroslavl Region, Russia

Maria Mozheyko, Sergey Eregin, Alexey Vigdorchik, David Hughes

Original Research

Variability in the Management of Nonvariceal Upper Gastrointestinal Bleeding in Europe: An Observational Study

Angel Lanas, Lars Aabakken, Jorge Fonseca, Zeynel Mungan, George Papatheodoridis, Hubert Piessevaux, Gianluca Rotondano, Javier Nuevo, Monica Tafalla

Open Access Original Research

Economic Evaluation of Levosimendan Versus Dobutamine for the Treatment of Acute Heart Failure in Italy

Carlo Lucioni, Alessandra D’Ambrosi, Silvio Mazzi, Piero Pollesello, Marjo Apajasalo, Francesco Fedele

Original Research

A UK Analysis of the Cost-Effectiveness of Humalog Mix75/25 and Mix50/50 Versus Long-Acting Basal Insulin

Richard F. Pollock, Bradley H. Curtis, Jayne Smith-Palmer, William J. Valentine

Erratum

Erratum to: Evaluation and Treatment of Gout as a Chronic Disease

Fernando Perez-Ruiz, Ana Maria Herrero-Beites

Latest issues

scroll for more

use your arrow keys for more

scroll or use arrow keys for more

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin

Prof. Florian Limbourg

Prof. Anoop Chauhan

Developed by: Springer Medicine

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.